Levels of sVCAM-1 and sICAM-1 in patients with Lyme disease

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 4, 2009, Pages 200-204

  Biesiada, Grazyna ^a   Czepiel, Jacek ^a   Sobczyk Krupiarz, Iwona ^a   Salamon, Dominika ^a   Garlicki, Aleksander ^a   Mach, Tomasz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Endothelial activation markers; Lyme disease; SICAM 1; SVCAM 1

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL;

EID: 67149136400     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.652     Document Type: Article

References (20)

1. Kondrusik M, Swierzbińska R, Zajkowska JM, et al. [Levels of proinflammatory cytokines: IL-1, IL-6, IL-8, TNF-alpha and receptor IL-6R in Lyme borreliosis]. Pol Merkur Lekarski. 1999; 7:218-220. Polish.
2. Lewczuk P, Reiber H, Korenke GC, et al. Intrathecal release of slCAM-1 into CSF in neuroborreliosis-increased brain-derived fraction. Neuroim-munol. 2000; 103:93-96.
3. Gryczyńska A. [Ecology of Lyme disease-the role of vertebrates]. Wiad Ekolog. 1997; 3:207-222. Polish.
4. Sellati TJ, Abrescia LD, Radolf JD, Furie MB. Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect Immun. 1996; 64: 3180-3187.
5. Hubálek Z, Halouzka J. Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review. Eur J Epidem. 1997; 13: 951-957.
6. Asbrink E, Hovmark A. Lyme borreliosis. Clin Dermatol. 1993; 11: 329-330.
7. Asbrink E, Hovmark A. Classification, geographic variations, and epidemiology of Lyme borreliosis. Clin Dermatol. 1993; 11: 353-357.
8. Aberer E. Lyme borreliosis-an update. J Dtsch Dermatol Ges. 2007; 5:406-414.
9. Bratton RL, Whiteside JW, Hovan MJ, et al. Diagnosis and treatment of Lyme disease. Mayo Clin Proc. 2008; 83: 566-571.
10. Marques A. Chronic Lyme disease: a review. Infect Dis Clin North Am. 2008; 22: 341-360.
11. Pietruczuk M, Pietruczuk A, Pancewicz S, Hermanowska-Szpakowicz T. [ICAM-1: structure, biological role and clinical significance]. Pol Merkur Lekarski. 2004; 17:507-11. Polish.
12. Flisiak R, Wierciriska-Drapalo A, Prokopowicz D. Immunology reaction in patients with arthritis in the course of borreliosis with Lyme disease. Przegl Epidemiol. 1996; 50:3.
13. Flisiak R, Pancewicz S. [Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases]. Przegl Epidemiol. 2008; 62:193-199. Polish.
14. Hermanowska-Szpakowicz T, Swierzbihska R, Zajkowska JM, et al. [Actual diagnostic possibilities of Lyme disease diagnosis]. Pol Merkur Lekarski. 2000; 8:69-71. Polish.
15. Zajkowska JM, Izycka A, Jablonska E, et al. [Serum and cerebrospinal concentrations of slCAM-1, slCAM-2, slCAM-3 in neuroborreliosis and tick borne encephalitis-preliminary report], Pol Merkur Lekarski. 2005; 19:152-157. Polish.
16. Zajkowska J, Grygorczuk S, Kondrusik M, et al. [Concentrations of soluble forms of adhesive particles: sVCAM-1, sPECAM-1, sVAP in eariy localized and late disseminated borreliosis]. Pol Merkur Lekarski. 2006; 21: 459-464. Polish.
17. Pietruczuk M, Pietruczuk A, Pancewicz S, et al. [Intercellular adhesion molecules slCAM-1, slCAM-2, slCAM-3 and IFNgamma in neuroborreliosis and tick-borne encephalitis. Przegl Epidemiol]. 2006; 60:109-117. Polish.
18. Ljostad U, Henriksen TH. Management of neuroborreliosis in European adult patients. Acta Neurol Scand Suppl. 2008; 188: 22-28.
19. Rupprecht TA, Koedel U, Fingede V, et al. The pathogenesis of Lyme neuroborreliosis: from infection to inflammation. Mol Med. 2008; 14: 205-212.
20. Pachner AR, Steiner I. Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol. 2007; 6: 544-552.